Norman Schwartz

ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of cancer immunotherapy products. The company was founded by Eamonn P. Hobbs and Charles J. Link Jr. in March 2018 and is headquartered in Fort Lauderdale, FL.

RainDance Technologies, Inc. engages in the development and commercialization of professional laboratory system. It develops and manufactures genomic tools for non-invasive liquid biopsy applications for the research, early detection, treatment of cancer, and inherited and infectious diseases. The company was founded by Andrew Griffiths, Darren R. Link, and Jerome Bibette in 2004 and is headquartered in Billerica, MA.

Part of Bio-Rad Laboratories, Inc., Bio-Rad Services UK Ltd. is a private company that specializes in developing, manufacturing, and marketing innovative products for the life science research and clinical diagnostic markets. The company is based in Watford, UK. The British company's products are verified for quality, purity, and performance through certificates of analysis (COAs), which can be obtained by catalog number and lot or batch number.

Founded in 1990, Bio-Metrics (U.K.) Ltd. is a British laboratory services company that is part of Bio-Rad Laboratories, Inc. The private company is based in Watford, UK and provides laboratory services.

Advanced Medical Technology Association is a trade association which provides medical technology solutions. The company was founded in 1974 and is headquartered in Washington, DC.

Part of Bio-Rad Laboratories, Inc., Bio-Rad AbD Serotec GmbH is a supplier and manufacturer of antibodies, reagents, and kits. The private company is based in Puchheim, Germany. The German company offers a wide range of custom antibody services, including bulk antibody production, antibody conjugation, and hybridoma production and services. The company's Pioneer Antibody Discovery team of scientists and technical specialists is assigned to every project to ensure a bespoke service tailored according to each client's success criteria. The CEOs of the company are Norman D. Schwartz, Lee Keron Marles.

Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020.

Part of Advanced Medical Technology Association, AdvaMedDx operates as a trade association representing diagnostics manufacturers. The private company is based in Washington. The CEO of the American company is Scott Whitaker.

Bio-Rad SAS is a French company that specializes in developing and manufacturing products for the life science research and clinical diagnostic markets. The private company is based in Marnes-la-Coquette, France. The company's focus is on accelerating biopharmaceutical and biotherapeutic method, process development, manufacturing, release testing, quality control, and patient monitoring with resources and workflows. The company is committed to helping the scientific community change the world through innovative products. The company was founded in 2012. Norman D. Schwartz has been the CEO of the company since 2021.